Alcon Inc (ALC)
79.57
-1.19
(-1.47%)
USD |
NYSE |
Apr 24, 16:00
79.57
0.00 (0.00%)
After-Hours: 20:00
Alcon Market Cap: 39.25B for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 39.25B |
| April 23, 2024 | 39.83B |
| April 22, 2024 | 39.76B |
| April 19, 2024 | 39.24B |
| April 18, 2024 | 38.70B |
| April 17, 2024 | 38.97B |
| April 16, 2024 | 39.27B |
| April 15, 2024 | 40.00B |
| April 12, 2024 | 40.09B |
| April 11, 2024 | 40.60B |
| April 10, 2024 | 40.54B |
| April 09, 2024 | 40.78B |
| April 08, 2024 | 41.35B |
| April 05, 2024 | 41.83B |
| April 04, 2024 | 41.24B |
| April 03, 2024 | 41.47B |
| April 02, 2024 | 40.30B |
| April 01, 2024 | 40.46B |
| March 28, 2024 | 41.08B |
| March 27, 2024 | 41.08B |
| March 26, 2024 | 40.76B |
| March 25, 2024 | 40.92B |
| March 22, 2024 | 41.24B |
| March 21, 2024 | 41.39B |
| March 20, 2024 | 41.73B |
| Date | Value |
|---|---|
| March 19, 2024 | 41.79B |
| March 18, 2024 | 41.50B |
| March 15, 2024 | 41.92B |
| March 14, 2024 | 42.38B |
| March 13, 2024 | 43.08B |
| March 12, 2024 | 43.47B |
| March 11, 2024 | 43.48B |
| March 08, 2024 | 43.05B |
| March 07, 2024 | 42.87B |
| March 06, 2024 | 42.30B |
| March 05, 2024 | 41.93B |
| March 04, 2024 | 42.37B |
| March 01, 2024 | 42.78B |
| February 29, 2024 | 41.70B |
| February 28, 2024 | 42.27B |
| February 27, 2024 | 40.04B |
| February 26, 2024 | 39.72B |
| February 23, 2024 | 39.49B |
| February 22, 2024 | 39.66B |
| February 21, 2024 | 39.35B |
| February 20, 2024 | 38.63B |
| February 16, 2024 | 38.25B |
| February 15, 2024 | 38.41B |
| February 14, 2024 | 37.70B |
| February 13, 2024 | 36.91B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
19.46B
Minimum
Mar 23 2020
43.48B
Maximum
Mar 11 2024
33.97B
Average
34.33B
Median
Jan 15 2021
Market Cap Benchmarks
| AC Immune SA | 234.39M |
| CRISPR Therapeutics AG | 4.724B |
| Addex Therapeutics Ltd | 16.62M |
| NLS Pharmaceutics Ltd | 5.415M |
| Molecular Partners AG | 127.47M |
Market Cap Related Metrics
| PE Ratio | 40.60 |
| PS Ratio | 4.175 |
| PEG Ratio | 0.2109 |
| Price to Book Value | 1.903 |
| Price | 79.57 |
| Earnings Yield | 2.46% |
| PEGY Ratio | 0.2105 |
| Operating PE Ratio | 38.00 |
| Normalized PE Ratio | 40.60 |